UK-headquartered pharma company AstraZeneca has weighed into the debate about the country's place in the European Union, saying it supports staying in the trading bloc.
The technology known as CRISPR/Cas9 has been described as the 'holy grail' of genetic engineering, and has become the hottest research area because of its potential to cure many diseases by
AstraZeneca and the UK's Medical Research Council have unveiled a groundbreaking collaboration which will see them working hand-in-hand in a joint research facility in Cambridge in the UK.<
Pascal Soriot announces further restructuring plans for AstraZeneca, including additional sales job cuts and an external million-dollar partnership with Moderna Therapeutics. Pascal Soriot, AstraZeneca’s CEO, has announced further plans to turn around the drugmaker’s problems and...
